Davis Matthew W. (CIK 2094283) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-11). Recent activity: Buy AQST (50,000 shares), Buy AQST (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Buy | 50,000 | $0 |
| 2025-11-12 | Aquestive Therapeutics, Inc. (AQST) | Chief Development Officer | Buy | 50,000 | $0 |
Source: SEC Form 4 filings · as of 2026-03-11